Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
Leukemia · 2024-12 · 38 (12) · 2675-2684
DOI: 10.1038/s41375-024-02375-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, online erschienen am 16.09.2024. Verfasst von Mouhamad Khouja und 15 weiteren Autor:innen. Beteiligte Einrichtung: Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Mutation, DNA Copy Number Variations. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent studies highlighted genetic aberrations associated with prognosis in Mantle Cell lymphoma (MCL), yet comprehensive testing is not implemented in clinical routine. We conducted a comprehensive genomic characterization of 180 patients from the European MCL network trials by targeted sequencing of peripheral blood DNA using the EuroClonality(EC)-NDC assay. The IGH::CCND1 fusion was identified in 94% of patients, clonal IGH-V-(D)-J rearrangements in all, and 79% had ≥1 somatic gene mutation. The top mutated genes were ATM , TP53 , KMT2D , SAMHD1 , BIRC3 and NFKBIE . Copy number variations (CNVs) were detected in 83% of patients with RB1 , ATM , CDKN2A/B and TP53 being the most frequently deleted and KLF2 , CXCR4 , CCND1 , MAP2K1 and MYC the top amplified genes. CNVs and mutations were more frequently observed in older patients with adverse impact on prognosis. TP53 mut , NOTCH1 mut , FAT1 mut TRAF2 del , CDKN2A/B del and MAP2K1 amp were linked to inferior failure-free (FFS) and overall survival (OS), while TRAF2 mut , EGR2 del and BCL2 amp related to inferior OS only. Genetic complexity (≥3 CNVs) observed in 51% of analysed patients was significantly associated with impaired FFS and OS. We demonstrate that targeted sequencing from peripheral blood and bone marrow reliably detects diagnostically and prognostically important genetic factors in MCL patients, facilitating genetic characterization in clinical routine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.
- Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany.
- Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK.
- Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.
- Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Kiel, Germany.
ORCID-Profile: Mouhamad Khouja, Linmiao Jiang, Karol Pal, Binaya Regmi, Wolfram Klapper, Stefan K Alig, David Gonzalez de Castro, Eva Hoster, Christiane Pott
Zitieren
APA
Khouja, M., Jiang, L., Pal, K., Stewart, P. J., Regmi, B., Schwarz, M., Klapper, W., Alig, S. K., Darzentas, N., Kluin-Nelemans, H. C., Hermine, O., Dreyling, M., Gonzalez de Castro, D., Hoster, E., Pott, C., & European Mantle Cell Lymphoma Network (2024). Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials. Leukemia, 38(12), 2675-2684. https://doi.org/10.1038/s41375-024-02375-8
Vancouver
Khouja M, Jiang L, Pal K, Stewart PJ, Regmi B, Schwarz M, et al. Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials. Leukemia. 2024;38(12):2675-2684. doi:10.1038/s41375-024-02375-8
BibTeX
@article{Khouja2024,
author = {Khouja, Mouhamad and Jiang, Linmiao and Pal, Karol and Stewart, Peter James and Regmi, Binaya and Schwarz, Martin and Klapper, Wolfram and Alig, Stefan K and Darzentas, Nikos and Kluin-Nelemans, Hanneke C and Hermine, Olivier and Dreyling, Martin and Gonzalez de Castro, David and Hoster, Eva and Pott, Christiane and European Mantle Cell Lymphoma Network, European Mantle Cell Lymphoma Network},
title = {Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials},
journal = {Leukemia},
year = {2024},
volume = {38},
number = {12},
pages = {2675--2684},
doi = {10.1038/s41375-024-02375-8}
}
EUVIMED